Clinical Trial Update: Hydration and Contrast-Induced Nephropathy in Primary Angioplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing hydration to prevent contrast-induced nephropathy in patients undergoing primary angioplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy

Snippet

Sponsor: Ospedale Misericordia e Dolce | Conditions: Contrast Induced Nephropathy | Phase 4 | Status: COMPLETED